Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial"

Stephanie Reynolds; David Parra; Robert S. Rosenstein

doi:10.1161/CIRCULATIONAHA.111.056077

Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial"

Stephanie Reynolds, David Parra, Robert S. Rosenstein

Medicine

Research output: Contribution to journal › Letter

1 Scopus citations

Original language	English (US)
Pages (from-to)	e291
Journal	Circulation
Volume	125
Issue number	3
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.111.056077
State	Published - Jan 24 2012

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.111.056077

Cite this

Reynolds, S., Parra, D., & Rosenstein, R. S. (2012). Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial". Circulation, 125(3), e291. https://doi.org/10.1161/CIRCULATIONAHA.111.056077

Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation : An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial". / Reynolds, Stephanie; Parra, David; Rosenstein, Robert S.

In: Circulation, Vol. 125, No. 3, 24.01.2012, p. e291.

Research output: Contribution to journal › Letter

Reynolds, S, Parra, D & Rosenstein, RS 2012, 'Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial"', Circulation, vol. 125, no. 3, pp. e291. https://doi.org/10.1161/CIRCULATIONAHA.111.056077

Reynolds S, Parra D, Rosenstein RS. Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial". Circulation. 2012 Jan 24;125(3):e291. https://doi.org/10.1161/CIRCULATIONAHA.111.056077

Reynolds, Stephanie ; Parra, David ; Rosenstein, Robert S. / Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation : An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial". In: Circulation. 2012 ; Vol. 125, No. 3. pp. e291.

@article{b134c241ff6f43288b710ca5816979a8,

title = "Letter by Reynolds et al regarding article, {"}risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial{"}",

author = "Stephanie Reynolds and David Parra and Rosenstein, {Robert S.}",

year = "2012",

month = jan,

day = "24",

doi = "10.1161/CIRCULATIONAHA.111.056077",

language = "English (US)",

volume = "125",

pages = "e291",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation

T2 - An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial"

AU - Reynolds, Stephanie

AU - Parra, David

AU - Rosenstein, Robert S.

PY - 2012/1/24

Y1 - 2012/1/24

UR - http://www.scopus.com/inward/record.url?scp=84856425969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856425969&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.111.056077

DO - 10.1161/CIRCULATIONAHA.111.056077

M3 - Letter

C2 - 22271857

AN - SCOPUS:84856425969

VL - 125

SP - e291

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3

ER -